Delaying umbilical cord clamping after birth benefits newborn babies
Delaying clamping of the umbilical cord after birth benefits newborn babies, according to a systematic review published in The Cochrane Library. The authors found babies’ blood and iron levels were...
View Article65 metabolites in urine simultaneously measured by clinical IEM-by-NMR...
At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy...
View ArticleHospira announces EC approval of Inflectra, Europe's first biosimilar mAb...
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar...
View ArticleMount Sinai physician-scientists join DILIN to help find causes, diagnostics...
In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced...
View ArticleVaccination campaign led HBV to more than double rate of "breakout" mutations
A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine,...
View ArticleAdding danoprevir to treatment regimen for hepatitis C patients leads to high...
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the...
View ArticlePivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1...
Boehringer Ingelheim today announced new data from its Phase III clinical trial programme, STARTVerso, which evaluates faldaprevir in combination with pegylated interferon and ribavirin (PegIFN/RBV).
View ArticleNeonatal jaundice linked to pediatric asthma risk
Researchers have found that neonatal hyperbilirubinemia is associated with an increased risk for childhood asthma.
View ArticlePromethera Biosciences completes patient enrolment for first clinical trial...
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and...
View ArticleValley Presbyterian Hospital receives First 5 LA grant to implement Welcome...
Valley Presbyterian Hospital was awarded a $772,643 grant from First 5 LA to implement the 'Welcome Baby' prenatal and infant care program. The grant period is from December 1, 2013 through June 30,...
View ArticleGroups, insurers, officials mobilize for health law enrollment push
March 31 is the deadline for signing up for insurance, and young adults and minorities are among the groups being targeted.
View ArticleEngineering students create wearable treatment for infant jaundice
Around 60 percent of infants are born jaundiced and many spend their first days of life isolated underneath special lights that help them eliminate the excess bilirubin in their bloodstreams.
View ArticleHigh doses of steroids fail to improve outcomes in pediatric liver disease
A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of...
View ArticleFDA approves Takeda's Entyvio for severe active ulcerative colitis and...
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously...
View ArticleU.S. Preventive Services Task Force recommends hepatitis B screening for high...
A simple blood test can detect if a person is one of the two billion people worldwide infected with hepatitis B. And now the U.S. Preventive Services Task Force recommends that all teens and adults who...
View ArticleNew clinical guidelines on diagnosis and management of idiosyncratic DILI
New clinical guidelines on the diagnosis and management of idiosyncratic drug-induced liver injury (DILI) appear in the July issue of The American Journal of Gastroenterology.
View ArticleAlcoholic liver disease: an interview with Dr Vinood Patel, University of...
Alcoholic liver disease (ALD) is one of the leading causes of death worldwide and also in the UK. As its name indicates this disease arises due to consuming excessive amounts of alcohol (80 g/day) over...
View ArticleUW researchers develop smartphone app that detects newborn jaundice within...
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It...
View ArticleLiver injury caused by herbals and dietary supplements increases 20% in U.S....
New research shows that liver injury caused by herbals and dietary supplements increased from 7% to 20% in a U.S. study group over a ten-year period.
View ArticleFDA approves Epaned for treatment of symptomatic and asymptomatic heart failure
Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration...
View Article
